Zika Virus in Indonesia – Travel Health Alert
The CDC has issued a Level 2 travel health notice for Zika virus activity in Indonesia, specifically highlighted in cases among returning travelers from Bali. This notice advises all travelers visiting the region to implement preventive measures against mosquito-borne transmission.
Key Information
Transmission Routes:
- Mosquito-borne: Primarily transmitted by Aedes aegypti mosquitoes (active during daylight hours)
- Sexual transmission: Can occur during and after travel; virus may persist in bodily fluids
Affected Areas: Bali, Indonesia, with potential spread to other Indonesian regions.
Recommended Preventive Measures:
- Use EPA-registered insect repellents (DEET, picaridin, oil of lemon eucalyptus)
- Wear lightweight, long-sleeved clothing and long pants
- Stay in air-conditioned or screened accommodations
- Avoid areas with standing water where mosquitoes breed
- Practice safe sexual practices during and for at least 3 months after travel (or follow current CDC guidance)
Symptoms to Monitor
Zika infection symptoms typically appear 3–14 days after exposure and may include:
- Fever
- Rash
- Joint pain
- Headache and muscle aches
- Malaise
Important: Infection during pregnancy carries risk of congenital abnormalities. Pregnant individuals or those planning pregnancy should consult healthcare providers before travel.
Post-Travel Considerations
Returning travelers should:
- Monitor for symptoms for 14 days
- Seek medical evaluation if symptoms develop
- Practice mosquito bite prevention for 3 weeks to prevent local transmission
- Inform healthcare providers of travel history
Pharmacist's Note: While no specific antiviral therapy targets Zika virus, supportive care focuses on symptom management with acetaminophen or ibuprofen for fever and pain. Aspirin should be avoided until dengue is ruled out, as it increases hemorrhage risk in dengue infection. Pregnant or nursing travelers should consult pharmacists regarding insect repellent safety and any post-travel medications. Travelers should carry CDC-approved repellents from home, as availability and formulations vary internationally. Those taking medications should verify interactions with antimalarial prophylaxis if co-prescribed, as Zika-endemic areas often overlap with malaria transmission zones.
Additional Resources
For current guidance, visit the CDC Zika travel notice page or consult a travel medicine specialist before departure.